Valuation: GKB Ophthalmics Limited

Market Cap 265M 2.75M 2.41M 2.23M 2.06M 3.87M 3.95M 26.58M 10.41M 129M 10.33M 10.1M 446M P/E 2024
-15.6x
P/E 2025 -4.32x
Enterprise Value 280M 2.91M 2.55M 2.36M 2.18M 4.1M 4.18M 28.15M 11.02M 137M 10.94M 10.7M 473M EV / Sales 2024
0.43x
EV / Sales 2025 0.29x
Free-Float
23.1%
Yield 2024 *
-
Yield 2025 -
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
11/08/23 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
1 day-3.21%
1 week-4.89%
Current month-11.32%
1 month-10.49%
3 months-21.13%
6 months+6.78%
Current year+11.26%
1 week 56.5
Extreme 56.5
62.85
1 month 56.5
Extreme 56.5
65.22
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 09/12/1981
Director of Finance/CFO - 31/03/2019
Chief Administrative Officer 62 31/05/2024
Director TitleAgeSince
Chairman 84 09/12/1981
Director/Board Member 57 23/07/1996
Director/Board Member 68 19/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.21%-4.89%-25.77%-37.08% 3.1M
-2.51%-6.11%-32.26%-6.22% 88.79B
-3.04%-0.07%-22.26%-26.10% 33.56B
-3.94%-4.70%-6.93%-31.03% 13.91B
-0.23%+0.43% - - 9.79B
+0.33%-12.66%-28.28%+502.37% 1.88B
+2.27%+1.79%-30.69%-66.06% 1.4B
-2.19%-5.42%+21.60%-3.38% 872M
+0.92%+0.96%-38.58%-26.66% 837M
+0.24%-2.05%+43.65%-31.83% 764M
Average -1.14%-2.90%-13.28%+30.45% 15.18B
Weighted average by Cap. -2.50%-1.33%-26.65%-7.43%

Financials

2024 2025
Net sales 883M 9.17M 8.03M 7.42M 6.85M 12.91M 13.16M 88.64M 34.71M 431M 34.46M 33.7M 1.49B 1.09B 11.33M 9.92M 9.17M 8.46M 15.94M 16.25M 109M 42.87M 533M 42.56M 41.61M 1.84B
Net income -28.1M -292K -256K -236K -218K -411K -419K -2.82M -1.11M -13.74M -1.1M -1.07M -47.4M -70.45M -732K -641K -593K -547K -1.03M -1.05M -7.08M -2.77M -34.43M -2.75M -2.69M -119M
Net Debt -57.22M -595K -521K -481K -444K -837K -853K -5.75M -2.25M -27.97M -2.23M -2.18M -96.51M 15.59M 162K 142K 131K 121K 228K 232K 1.57M 613K 7.62M 609K 595K 26.3M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
170
Date Price Change Volume
14/07/26 ₹57.01 -3.21% 2,770
13/07/26 ₹58.90 -1.83% 1,656
10/07/26 ₹60.00 -1.61% 518
09/07/26 ₹60.98 +4.60% 4
08/07/26 ₹58.30 -2.74% 520